Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy
10.1186/s13058-015-0522-2
Saved in:
Similar Items
-
Hypocortisolism in survivors of severe acute respiratory syndrome (SARS)
by: Leow M.K.-S., et al.
Published: (2020) -
PEEC model for multiconductor systems including dielectric mesh
by: Jayabalan, J., et al.
Published: (2014) -
Prediction of acute-phase treatment outcomes by adding a single-item measure of activity impairment to symptom measurement: Development and validation of an interactive calculator from the star∗d and co-med trials
by: Jha, M.K., et al.
Published: (2021) -
Semaphorin signaling in cardiovascular development
by: Epstein J.A, et al.
Published: (2016) -
Increasing flower longevity in Alstroemeria
by: Chanasut U., et al.
Published: (2014)